Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Expert advises to invest 'wherever value takes you' after rate cut

Allan Small, a senior investment advisor of the Allan Small Financial Group with iA Private Wealth, joins Coreena Robertson in the Expert Exchange to analyze the Bank of Canada’s recent decision to cut interest rates by 50 basis points, the fourth cut th...
Coreena Robertson | November 1, 2024 |

BIGG Digital Assets, NetCents, Northern Data - who is the best blockchain pearl?

The Blockchain phenomenon has kept the world in a state of excitement in the second half of 2017. A revolution by many young entrepreneurs and investors seemed to be on the way. Business models were springing up like mushrooms. There were almost no barriers to market entry, as...
Mario Hose | July 17, 2020 |

Ovid Therapeutics Posts Positive Data from Phase 2 Seizure Reduction Trial

Ovid Therapeutics' shares are trading 25% higher today after the company reported positive initial data from its ENDYMION soticlestat phase 2 trial for patients with developmental and epileptic encephalopathies. Shares of Ovid Therapeutics Inc. (OVID:NASDAQ) are tra...
Streetwise Reports | September 25, 2019 |

Three safe-haven reasons to own gold

“It’s the tail that wags the dog” is defined by Urban Dictionary as a way of persuading a large group of people. The phrase is usually employed in a situation wherein a cause that expects to elicit a certain effect, is in fact reversed. ...
Richard (Rick) Mills | May 21, 2019 |

Will Gold Benefit from Trump Impeachment Proceedings?

This week, Nancy Pelosi announced that the House would launch a formal impeachment inquiry. Is it a well-grounded argument, publicity stunt or reflection of the growing polarization inside the Democratic party? Storm in a tea cup or not, should Trump be worried? And gold? W...
Arkadiusz Sieron | September 26, 2019 |

The Barriers to Investing in Private Equity Are Too High

The rich are getting richer and the poor are getting poorer, and for that we can largely blame policies of envy that increasingly restrict investors’ access to wealth-building instruments. Case in point: I was recently invited to participate in a pri...
Frank Holmes | October 15, 2019 |

Cerecor Shares Rise 13% on Sale of Pediatric Portfolio for $32 Million

Shares of Cerecor Inc. are trading higher today after reporting that it will sell its pediatric portfolio to Aytu BioScience for $32 million in a combination cash and stock deal. Biopharmaceutical company Cerecor Inc. (CERC:NASDAQ) , which focuses on development and ...
Streetwise Reports | October 16, 2019 |

Buzz on the Bullboards: A Deeper Look into New Energy Opportunities

It was hedge fund legend Ray Dalio who said: “He who lives by the crystal ball will eat shattered glass.” With a new President in the White House and a new administration, it is like a massive “reset” button is about to be ...
Stockhouse Editorial | January 20, 2021 |

Pundits Weigh In on Bob Moriarty's 'Basic Investing in Resource Stocks'

Bob Moriarty, veteran resource investor and founder of 321 Gold and 321 Energy , is known for speaking his mind, something that he does on his websites and in his books. His latest book , "Basic Investing in Resource Stocks: The Idiot's Guide," has made Amazon's bes...
Streetwise Reports | May 9, 2019 |

How to Unrig the Gold Market, According to GATA’s Chris Powell

In an earlier post, I gave you a sneak preview of my interview with Chris Powell, secretary/treasurer at Gold Anti-Trust Action Committee (GATA). For 20 years now, Chris and others at GATA have made it their mission to expose collusion by international financial institutions...
Frank Holmes | May 22, 2019 |
1 2 3 4 5 6